{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Science News Daily","title":"Merck Eyes Global Approval, Prisoners Dilemma Cooperation Emerges, HistoSonics Wins Asia Approval, AI Maps Autism and ADHD Paths, and more...","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/8cfb0f37\"></iframe>","width":"100%","height":180,"duration":628,"description":"(0:10): Sacituzumab Tirumotecan Boosts Survival in Endometrial Cancer; Merck Eyes Global Approval\n(2:21): Rutgers Study Reveals Natural Pathways to Cooperation in Prisoner's Dilemma Without Kinship or Rules\n(3:40): HistoSonics Gains Ground in Asia with TFDA Approval for Edison Histotripsy System\n(5:24): Swedish Study Expands to Predict Autism, ADHD Trajectories with AI by Age 10\n(7:54): GlucoBrain: Revolutionizing Diabetes-Dementia Research with 3D Microfluidic Biochip\nTo subscribe visit https://www.brief.news.\nFor more updates in your inbox each morning visit www.brief.news.\nImage credit: Rutgers University","thumbnail_url":"https://img.transistorcdn.com/je4-HZPgrBlk_-irwBJ1aU1GY9y3XNHXezHh1JTxzqw/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQ3MTgzLzE3MDY3/MjM4ODUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}